hypoglycaemia
Diabetic subjects with mutations in the gene encoding hepatocyte nuclear factor (HNF)-1alpha (MODY3) are prone to develop hypoglycaemia at low doses of glibenclamide, interpreted as sulphonylurea hypersensitivity.
Diabetic subjects with mutations in the gene encoding hepatocyte nuclear factor (HNF)-1alpha (<span class="gene" id="15787664-1-94-99">MODY3</span>) are prone to develop <span class="disease" id="15787664-1-122-135">hypoglycaemia</span> at low doses of glibenclamide, interpreted as sulphonylurea hypersensitivity.